KRAS is one of the most frequently mutated oncogenes in human cancers and remains a challenging target for therapeutic intervention, often labeled "undruggable." We herein synthesized triazole-containing peptidomimetics TTh1 and TTh2, to explore their select... ...

请注册登录后继续浏览